Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Wnt-10b is important for keeping mouse skin cells healthy for hair growth.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Both mouse and rat models are effective for testing alopecia areata treatments.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Researchers identified genes and proteins that may influence wool thickness in sheep.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

PRP is effective for treating hair loss, improving hair density, count, and thickness.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The project created a standardized system for classifying skin lesions in lab rats and mice.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.